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Abstract
Background: Visual impairment and blindness from diabetic retinopathy (DR), which can be reduced by early screening and
treatment, is an emerging public health concern in low-income and middle-income countries (LMICs) owing to the increasing
prevalence of diabetes mellitus (DM). However, no systematic screening exists in most LMIC settings. The Western province of
Sri Lanka has the highest prevalence of DM (18.6%) in the country. A situational analysis identified a marked gap in DR screening
(DRS) and treatment services uptake in this region; only opportunistic screening is practiced currently.
Objective: The aim of this protocol is to describe the methods of development and validation of a DRS intervention using a
hand-held nonmydriatic digital camera by physician graders in a non-ophthalmological setting at a tertiary-level medical clinic
to propose a valid and feasible modality to improve uptake.
Methods: DRS modality was developed after assessing barriers and identifying the most appropriate personnel, methods, and
location for screening services, following formative research work. The validation will be conducted in a public sector tertiary
care center in the Western province of Sri Lanka. The selected physicians will be trained on capturing and grading images according
to a valid locally adopted protocol. Two physicians rated high on training will screen a sample of 506 people with DM at a medical
clinic. They will use nonmydriatic and mydriatic 2-field imaging strategy. The validity of the proposed screening procedure will
be assessed and compared with the mydriatic indirect biomicroscopic examination by a senior retinologist.
Results: The validity of screening by physician graders will be analyzed and the sensitivity, specificity, and predictive values
(with 95% CIs) calculated by the dilation status and for each grader. The diagnostic accuracy at each level of severity of DR will
be assessed to define the most appropriate referable criteria. Data is currently being collected.
Conclusions: The outcome of this study will be useful for the detection of a defined level of DR at non-ophthalmological setting
to filter the people with DM before referral to an eye clinic. This will be helpful to improve the uptake and identify risk groups
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in advance to prevent sight-threatening DR. Furthermore, evidence from this study will be useful for the implementation of a
DRS program in this region and in similar communities.
International Registered Report Identifier (IRRID): PRR1-10.2196/10900
(JMIR Res Protoc 2018;7(12):e10900)   doi:10.2196/10900
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Introduction
The prevalence of diabetes mellitus (DM) and the number of
people affected by DM is increasing rapidly in all regions. The
International Diabetes Federation estimated that 425 million
people had diabetes in 2017, which will increase to 629 million
in 2045 globally [1]. This increase is expected to be the highest
in low-income and middle-income countries (LMICs) compared
with high-income countries (HIC) [2]. Diabetic retinopathy
(DR) is a common microvascular complication of DM, which
can lead to visual impairment and blindness if not detected early
and treated [3]. Many studies have reported that visual loss from
DR can be largely prevented by early screening and appropriate
treatment [4-6]. Diabetic retinopathy screening (DRS) can be
done in 2 ways, systematic screening similar to national-level
programs in HIC versus opportunistic screening and case
detection, which is common in low-income settings. Most
LMICs are unlikely to have full population-based screening
program owing to resources constraints. The current method of
DRS in most LMICs is direct ophthalmoscopy, which has a
lower diagnostic accuracy and found to be ineffective even after
training [7]. The mydriatic biomicroscopic examination by an
ophthalmologist is practically not possible in these countries
owing to a low number of ophthalmologists, and eye clinics are
overburdened with highly prevalent blinding conditions such
as cataract [8].
The reasons for the unavailability of DRS programs (DRSPs)
in LMIC settings are mostly attributed to the lack of skilled
human resources, financial resources, and evidence of what
works in the local system [9-11]. Therefore, it would be
important to understand the approaches for screening, especially
in non-ophthalmological settings. Conventional digital cameras
need a larger space, skilled photographers, and large image
storage devices. In addition, systematic screening using
sophisticated table-top imaging systems incur high capital
investment though they are cost-effective [12]. Hand-held digital
cameras are easy to move, require minimum space, minimum
power consumption, and are user-friendly [13]. In addition,
nonmydriatic hand-held cameras are less discomforting to
participants and can be used while people with DM are waiting
in front of a physician for consultation. The usage of a camera
without pupil dilatation is comfortable to people with DM, as
well as easy for providers. However, the latter depends on the
quality of the image available for grading [14].
Various photographic studies have looked at the diagnostic test
accuracy of DRS using digital imaging. Most of these studies
used static table-top imaging systems and were conducted in
HICs. These studies have shown a sensitivity of 68%-97% and
a specificity of 71%-100% in nonmydriatic imaging using
ophthalmic human resources as index graders [15-18]. Similarly,
in mydriatic imaging, most of the studies have used table-top
imaging systems, ophthalmic human resources as index test
graders, and were conducted in HICs. These studies have shown
a sensitivity of 77%-97% and a specificity of 76%-98% in
mydriatic digital imaging [19-22]. There is a gap in evidence
in digital retinal imaging in LMICs using non-ophthalmic human
resources. In addition, the usage of context-specific imaging
systems, such as hand-held digital retinal camera, in
non-ophthalmic setting was not reported in the current literature.
Sri Lanka has achieved remarkable development in the health
sector; however, there are public health concerns such as DR
which have not been addressed to date [23]. The crude
prevalence of DM in Sri Lanka was 12.6% (>20 years), being
highest in the Western province (18.6%, 95% CI 15.8%-21.5%)
[24]. In the Western province, there are approximately 750,000
(age>18 years) people with DM, 20% (150,000/750,000) of
whom are likely to have nonproliferative DR (NPDR). A
situational analysis conducted in this region has shown that the
number of people undergoing opportunistic screening and free
treatment in the public sector was far lower than the estimated
need [25]. There is no systematic DRS in the Western province
despite the high prevalence of DM [25]. In addition, there is no
published data on this topic from Sri Lanka. The aim of this
protocol is to describe the methods of validation of a DRS
approach using digital imaging by physician graders in a
tertiary-level public sector medical clinic. This study will
demonstrate the functional and technical feasibility of using a
hand-held digital camera in an LMIC non-ophthalmological
setting and assess the diagnostic accuracy.
Methods
Ethics Approval
Ethics review committees of National Eye Hospital (Colombo,
Sri Lanka) and London School of Hygiene & Tropical Medicine
(United Kingdom) granted ethics approval.
Development of the Diabetic Retinopathy Screening
Modality and Training
The initial formative research showed that nonmydriatic digital
retinal imaging at medical clinics by general physicians was a
potential option for the local setting. We selected 9 general
physicians from a tertiary-level institution following informed
consent, and they underwent a competency-based training by
2 retinologists from a tertiary center, which included the
following: capturing retinal fields using a hand-held fundus
camera, identification of signs of DR (including macular signs)
using images, and DR grading according to an adapted
JMIR Res Protoc 2018 | vol. 7 | iss. 12 | e10900 | p.2http://www.researchprotocols.org/2018/12/e10900/
(page number not for citation purposes)
Piyasena et alJMIR RESEARCH PROTOCOLS
XSL•FO
RenderX
classification system (Table 1). DR signs are graded at 4 levels
as follows: none=R0, mild NPDR=R1, moderate NPDR=R2,
severe NPDR=R3, and proliferative DR and above=R4. Macular
changes are graded as follows: none=M0 (maculopathy absent)
and exudate(s) or blot hemorrhage(s) within 2-disc diameters
from the center of the fovea=M1 (maculopathy present).
Guidelines were used to standardize reporting of image quality,
which included ungradable images based on the proportion of
the retina visible for grading (Figure 1). After the training,
physicians were tested using a set of standard images of DR,
and the two physicians who reached the required level of
agreement with the retinologists (κ=.8-.9) were selected as
graders in the validation study.
Table 1. Adapted diabetic retinopathy classification for the validation study.
PDRd (R4)Severe NPDR (R3)Moderate BDR or
NPDR (R2)
Mild BDRb or
NPDRc (R1)
No DRa (R0)Signs
PresentMultipleMultipleFewNoMicroaneurysms
PresentMultipleMultipleFewNoHard exudatese
PresentMultipleMultipleOccasionalNoCotton wool spots
Present>20 in 4 quadrants>20 in 1-3 quadrantsFewNoIntraretinal hemorrhagee
PresentPresent in >2 quad-
rants
Present in 1-2 quad-
rants
OccasionalNoVenous beading
PresentProminent >1 quad-
rant
Present ~1 quadrantNoNoIRMAf
PresentNoNoNoNoNVDg
PresentNoNoNoNoNVEh
Present—advanced
PDR
NoNoNoNoVitreous or preretinal hemorrhage
Present—advanced
PDR
NoNoNoNoTraction
Present—advanced
PDR
NoNoNoNoFibrosis
aDR: diabetic retinopathy.
bBDR: Background DR.
cNPDR: nonproliferative DR.
dPDR: proliferative DR.
eNot within the definition of maculopathy.
f IRMA: Intraretinal microvascular abnormalities.
gNVD: Neovascularizations over the disc.
hNVE: Neovascularizations elsewhere.
Figure 1. Evaluation of image quality-levels of gradeability based on the proportion of the image that can be graded.
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Sample Calculation and Recruitment
The sample size (n=405) was calculated on the basis of 95%
CIs, 10% margin of error, expected sensitivity 70%, and the
prevalence of moderate NPDR among people with DM of 20%.
Then, we inflated the sample size by an additional 25% (n=101,
total n=506) to take account of ungradable images. An interim
analysis will be undertaken to ascertain the level of ungradable
images (ie, <50% of the retina visible) and the sample size
increased, if required.
This study is a prospective observational study by design. A
consecutive sample of diagnosed people with DM (age >18
years) without previous DRS at an eye clinic will be eligible to
participate, after giving written informed consent. Eligible
participants will be recruited by trained research assistants when
people with DM present for routine medical care at the main
tertiary center in Colombo. People with DM with previous
retinal screening, DR-related treatment (laser treatment,
intravitreal injections, and pars plana vitrectomy), and those
who were currently under any DRSP or treatment will be
excluded from the study. Figure 2 shows the participants’ flow
diagram. Participants’ characteristics will be documented in a
questionnaire schedule by research assistants on recruitment.
Figure 2. Participants' flow diagram in the validation.
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Figure 3. Two retinal fields captured.
Imaging System, Capturing Images, and Grading
Two-field nonmydriatic and mydriatic retinal images will be
captured and stored (Figure 3). Participants will undergo digital
retinal imaging (using VISUSCOUT100 hand-held nonmydriatic
fundus camera-2017; Carl Zeiss, Germany) by the physician
graders at the time of presentation. This imaging system has a
40° field-of-view with 5 megapixels (type of camera sensor:
complementary metal-oxide semiconductor; resolution 800×480)
and captures color and red-free images in a focus range of −20
D (diopters) to +20D. The minimum pupil size required is 3.5
mm, and 9 light-emitting diodes are available for internal
fixation.
First, 2-field (first field-macula centered, second field-disc
centered; Figure 3), 40° retinal images will be captured in each
eye by each physician grader without pupillary dilatation.
Subsequently, participants’ pupils will be dilated using 2.5%
phenylephrine, and the same fields will be captured, following
adequate mydriasis (5-6 mm).
Each set of images will be coded and stored by research
assistants after capturing. The coded image sets will be given
back to the same physician graders for grading. During grading,
nonmydriatic images will be graded first. The graders will be
masked to the history and clinical examination findings. The
retinopathy and macular signs will be identified and entered by
physician graders into a hardcopy data table. Finally, it will be
entered into a Microsoft Excel datasheet by research assistants.
The grading data consistency checks and cleaning will be done
by an independent statistician.
Reference Test
The reference test will entail a detailed, dilated fundus
examination by an experienced retinologist using slit-lamp
biomicroscopy with a 90D lens and indirect ophthalmoscopy
using a 20D lens. After imaging, this examination will take
place as early as possible. The retinologist will be masked to
the clinical status and physician graders’ findings. In addition,
a detailed anterior segment examination (clarity of cornea and
status of the lens) and media (vitreous) examination will be
done by the reference test grader. The lens opacity will be graded
according to the lens opacity classification system, version 111.
Quality Assurance and Agreement Analysis
For quality assurance, 15% of each nonmydriatic and mydriatic
image sets will be evaluated by the retinologist for technique,
ability to image the required field, and gradeability. Then, 15%
of each hundred image sets will be given back to physician
graders for double grading to assess the repeatability and
intragrader agreement in the first and second attempts of grading
images. A sample of the same image sets (n=200) will be graded
by the retinologist to calculate the intergrader agreement.
Data Analysis
We will analyze the validity of screening by physician graders
and calculate the sensitivity, specificity, and predictive values
with 95% CIs for each method of screening and by the grader.
The analysis will be conducted by including and excluding
ungradable images and considering each eye as a unit of analysis
and by a person considering the worst eye. Intragrader and
intergrader agreement (kappa) for both mydriatic and
nonmydriatic index tests will be calculated and compared with
the findings by the retinologist. A subgroup analysis will be
conducted for the identification of the presence or absence of
DR (any DR), moderate NPDR, and above with or without
macular signs to make recommendations for a referable criterion
for the local context in DRS by physician graders.
Results
The physician graders have been trained, and currently,
validation is being done in the Western province of Sri Lanka.
The results of this study will be published in detail according
to the Quality Assessment of Diagnostic Accuracy Study
guidelines [26]. Data will be entered using a Microsoft Excel
(2016) worksheet and transferred into STATA/IC-v14.2
analytical package following cleaning, consistency checks, and
analysis. The sensitivity, specificity, and predictive values for
each strategy and each level of DR will be presented using the
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same variables of 2 physician graders (nonmydriatic and
mydriatic separately) compared with the reference standard,
along with 95% CIs.
Discussion
The level of skills acquired by physician graders is an important
factor in the screening outcome. Different non-ophthalmologist
graders have successfully conducted DRS in some settings
[27-29]. We will describe the diagnostic accuracy of the
detection of DR by physician graders. In addition, we will be
able to study the effect of a range of population characteristics
on the validity of detecting DR using imaging and understand
the role of non-ophthalmic personnel to make recommendations
for a systematic DRSP. In addition, we will describe the referral
criterion applicable to this local context based on the validation
study results. Defining a referable level DR at a
non-ophthalmological setting, in a context where there is no
systematic DRS, will filter out those not needing a referral and
therefore reduce the workload at an ophthalmologist’s clinic.
The 7-field imaging strategy used in early treatment diabetic
retinopathy study is considered as the gold standard in DRS
[30]. However, this technique is practically not feasible in this
context owing to resources constraints. Therefore, we proposed
to use the locally accepted reference standard of retinologists’
examination as the suitable reference standard. Digital retinal
imaging has previously shown diagnostic accuracy levels that
would comply with the accepted standards of established
national-level screening programs [15,22,31].
A few studies (conducted in HICs) have used
non-ophthalmologist human resources in DRS, with which we
could compare our results. In Singapore, a nonmydriatic fundus
camera showed a sensitivity of 69.8% (95% CI 61.3%-77.2%)
and a specificity of 94.4% (95% CI 92.3%-96.1%) for
nonphysician graders using a single field [32]. A study in the
United Kingdom on DRS by general practitioners using 35-mm
color images showed that detecting any level of DR increased
from 62.6% (95% CI 55.9%-69.4%) with direct ophthalmoscopy
to 79.2% (95% CI 73.6%-84.9%) using retinal photographs,
and specificity remained unchanged (direct ophthalmoscopy
75.0% [95% CI 69.5%-80.5%] vs 73.5% [95% CI
68.0%-79.1%]) [33]. They concluded that retinal photography
by trained general practitioners in primary care settings could
attain an acceptable level of detection of sight-threatening DR
(87%) [33]. In Thailand, the use of single-field digital
nonmydriatic imaging showed a sensitivity of 80% and a
specificity of 96% in a sample of people with DM, where 54.7%
people with DM were aged 41-60 years and 45.3% people with
DM had diabetes since 1-5 years [34].
Another important consideration in this study would be the
gradeability of images. The image gradeability will depend on
the lens opacity, media opacity, pupil size, and reflectivity of
the fundus. We envisaged poor gradeability in nonmydriatic
imaging considering the high prevalence of cataract in this local
setting. Furthermore, iris color, age, and other population
characteristics may affect the quality of images [14]. Scanlon
et al showed that in the >80-years age group, the technical failure
rates reduced from 41.6% to 16.9% following mydriasis. This
study concluded that the odds of having one eye ungradable
increases by 2.6% (95% CI 1.6%-3.7%) for each extra year
since the diagnosis of DM and major cause of ungradability
was having central cataract (57%) [35]. We will describe the
factors affecting gradeability of images in addition to the
diagnostic test accuracy results.
In this study, we will demonstrate the diagnostic accuracy of
physician graders compared with the retinologist to make
recommendations for developing an integrated DRSP in LMICs
where there is no systematic DRS. The outcome of this study
will be useful for the implementation of a systematic DRSP in
this region and similar communities.
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